Published in Am J Clin Pathol on August 01, 1994
Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol (1998) 1.62
Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies. Diagn Pathol (2011) 1.57
Early regeneration of thymic progenitors in rhesus macaques infected with simian immunodeficiency virus. J Exp Med (1998) 1.39
Induction of lymphocyte proliferation and severe gastrointestinal disease in macaques by a nef gene variant SIVmac239. Am J Pathol (1996) 1.22
p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival. Br J Cancer (1996) 1.04
MIB-1 proliferative activity in invasive breast cancer measured by image analysis. J Clin Pathol (1996) 0.99
Comparison of Ki-67 equivalent antibodies. J Clin Pathol (2002) 0.97
Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy. Br J Cancer (2008) 0.87
Proliferative activity in human glioblastomas: evaluation of different Ki67 equivalent antibodies. Mol Pathol (1997) 0.83
PI3KCA mutations and/or PTEN loss in Her2-positive breast carcinomas treated with trastuzumab are not related to resistance to anti-Her2 therapy. Virchows Arch (2012) 0.83
Prognostic significance of MIB1-determined proliferative activities in intraductal components and invasive foci associated with invasive ductal breast carcinoma. Br J Cancer (1999) 0.79
A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample. BMC Cancer (2005) 0.78
Prognostic value of MIB-1 index and DNA ploidy in resectable ampulla of Vater carcinoma. Ann Surg (1999) 0.77
A comparative study of cell proliferation markers in breast carcinomas. Clin Mol Pathol (1995) 0.76
Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359)). J Virol (2001) 0.76
Diagnostic implications of Ki-67 expression in adipocytes and lipoblasts: an immunohistochemical study. Int J Clin Exp Pathol (2014) 0.75
Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet (1993) 11.38
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol (1994) 3.48
Twist is a potential oncogene that inhibits apoptosis. Genes Dev (1999) 3.14
High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol (1999) 2.80
Optical coherence tomography in pediatric patients: a feasible technique for diagnosing celiac disease in children with villous atrophy. Dig Liver Dis (2009) 2.69
bcl-2 expression in pleural and extrapleural solitary fibrous tumours. J Pathol (1997) 2.66
Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol (2000) 2.56
p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol (2001) 2.19
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol (2001) 2.13
Sentinel node mapping during laparoscopic distal gastrectomy for gastric cancer. Surg Endosc (2007) 2.12
CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol (2003) 2.01
Clear cell ("sugar") tumor of the lung is a lesion strictly related to angiomyolipoma--the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology (1994) 1.88
PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables. J Clin Pathol (1992) 1.86
Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa. Ann Oncol (2006) 1.71
Design and initial implementation of a regional tele-oncology project. J Telemed Telecare (2000) 1.70
TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst (2012) 1.65
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies. Diagn Pathol (2011) 1.57
Pulmonary sarcoidosis: the 'Great Pretender'. Clin Radiol (2010) 1.55
Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy. Cancer J Sci Am (2006) 1.54
The virtual case: a new method to completely digitize cytological and histological slides. Virchows Arch (2001) 1.46
p53 Protein expression in nevi and melanomas. Arch Dermatol (1993) 1.44
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Clin Cancer Res (1995) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Fibroepithelial tumor of the breast with digital fibroma-like inclusions in the stromal component. Case report with immunocytochemical and ultrastructural analysis. Am J Surg Pathol (1994) 1.38
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease. Histopathology (1992) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene (1992) 1.30
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis. Oncogene (2011) 1.26
Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. Am J Pathol (1998) 1.24
Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle. Mucosal Immunol (2013) 1.22
Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology (2004) 1.20
Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant (2008) 1.20
Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions. Br J Haematol (1996) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma. Leukemia (2007) 1.19
Expression of progesterone receptors in solid-cystic tumour of the pancreas: a clinicopathological and immunohistochemical study of ten cases. Virchows Arch A Pathol Anat Histopathol (1993) 1.18
Endoscopic ultrasound-guided application of a new hybrid cryotherm probe in porcine pancreas: a preliminary study. Endoscopy (2008) 1.17
Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms. J Pathol (1992) 1.16
Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up. Hum Pathol (1996) 1.15
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. Mod Pathol (2009) 1.15
Clear cell tumor and angiomyolipoma. Am J Surg Pathol (1991) 1.14
Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up. Clin Cancer Res (1996) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Use of calretinin in the differential diagnosis of unicystic ameloblastomas. Histopathology (2001) 1.13
Cyclin D3 expression in normal, reactive and neoplastic tissues. J Pathol (1998) 1.13
Proliferating cell nuclear antigen expression in central nervous system neoplasms. Virchows Arch A Pathol Anat Histopathol (1991) 1.13
Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma. Breast Cancer Res Treat (1996) 1.12
Low expression of p27 and low proliferation index do not correlate in hairy cell leukaemia. Br J Haematol (2000) 1.11
Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-east Italy: a prospective, descriptive survey. The Italian Ulcer Study Group "GISU". Dig Liver Dis (2001) 1.11
Telepathology using Internet multimedia electronic mail: remote consultation on gastrointestinal pathology. J Telemed Telecare (1996) 1.10
Gastric endocrine cell proliferation. Association with Zollinger-Ellison syndrome. Arch Pathol (1974) 1.09
Ghrelin-producing epsilon cells in the developing and adult human pancreas. Diabetologia (2008) 1.09
Ultraviolet-induced p53 mutations in atypical fibroxanthoma. Am J Pathol (1994) 1.08
Antibiotic treatment for low-grade gastric MALT lymphoma. Lancet (1994) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Calretinin expression in ameloblastomas. Histopathology (2000) 1.06
HPV triage of women with atypical squamous cells of undetermined significance: a 3-year experience in an Italian organized programme. Cytopathology (2005) 1.05
p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene (1996) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival. Br J Cancer (1996) 1.04
Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol (2007) 1.04
Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67. Acta Neuropathol (1987) 1.04
Tumor suppressor genes and related molecules in leiomyosarcoma. Am J Pathol (1996) 1.03
Fine-needle aspiration cytology of the breast: a preliminary report on telepathology through Internet multimedia electronic mail. Mod Pathol (1997) 1.02
Distinct patterns of calcium transients during early and delayed afterdepolarizations induced by isoproterenol in ventricular myocytes. Circulation (1995) 1.02
Cyclin-D1-gene amplification and expression in breast carcinoma: relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21WAF1 immunohistochemical expression. Int J Cancer (1997) 1.02
Bax immunohistochemical expression in breast carcinoma: a study with long term follow-up. Int J Cancer (1998) 1.01
c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical study. Eur J Cancer (1994) 1.01
Basaloid squamous cell carcinoma of the head and neck: clinicopathological features and differential diagnosis. Ann Otol Rhinol Laryngol (1996) 1.01
mdm2 gene alterations and mdm2 protein expression in breast carcinomas. J Pathol (1995) 1.01